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Abstract
Background: This study aimed at providing information for priority setting in the health care
sector of Zimbabwe as well as assessing the efficiency of resource use. A general approach
proposed by the World Bank involving the estimation of the burden of disease measured in
Disability-Adjusted Life Years (DALYs) and calculation of cost-effectiveness ratios for a large
number of health interventions was followed.
Methods: Costs per DALY for a total of 65 health interventions were estimated. Costing data
were collected through visits to health centres, hospitals and vertical programmes where a
combination of step-down and micro-costing was applied. Effectiveness of health interventions was
estimated based on published information on the efficacy adjusted for factors such as coverage and
compliance.
Results: Very cost-effective interventions were available for the major health problems. Using
estimates of the burden of disease, the present paper developed packages of health interventions
using the estimated cost-effectiveness ratios. These packages could avert a quarter of the burden
of disease at total costs corresponding to one tenth of the public health budget in the financial year
1997/98. In general, the analyses suggested that there was substantial potential for improving the
efficiency of resource use in the public health care sector.
Discussion: The proposed World Bank approach applied to Zimbabwe was extremely data
demanding and required extensive data collection in the field and substantial human resources. The
most important limitation of the study was the scarcity of evidence on effectiveness of health
interventions so that a range of important health interventions could not be included in the cost-
effectiveness analysis. This and other limitations could in principle be overcome if more research
resources were available.
Conclusion: The present study showed that it was feasible to conduct cost-effectiveness analyses
for a large number of health interventions in a developing country like Zimbabwe using a consistent
methodology.
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Background
There is an increasing number of cost-effectiveness studies
aiming at analysing the allocative efficiency of the health
care sector. These analyses incorporate costs and effects of
interventions directed at different health problems and
different patient groups and often include a large number
of interventions. Examples from developed countries
include analyses performed in United Kingdom [1], Aus-
tralia [2] and in Oregon State in the USA [3] while a large
database on cost-effectiveness analyses from all over the
world is maintained by an American university [4]. For
developing countries, the World Bank health sector prior-
ities review [5-7] assessed the costs and effectiveness of
health interventions directed at major health problems for
low and middle income regions of the world. In a similar
effort, the World Health Organization estimated costs per
DALY for a wide range of health interventions for 14 epi-
demiologic sub regions and in addition developed tools
enabling individual countries to perform similar cost-
effectiveness analyses based on local estimates on e.g. dis-
ease burden and unit costs of various health services [8-
10]. At an individual country level, a list of costs per dis-
counted life year gained for a large number of preventive
and curative health interventions was developed for
Guinea [11].
While such cost-effectiveness analyses aiming at assessing
allocative efficiency may be very useful for setting priori-
ties in the health care sector of a given country, several fea-
tures of this technique have been identified as being
problematic. Since these analyses often include a large
number of health interventions, these exercises are
extremely data intensive in terms of estimating the
required information on costs and effectiveness. Conse-
quently, simplifying assumptions and shortcut methods
have been applied in order to make the data collection
task more manageable. For instance, it is often assumed
that health interventions are produced under constant
returns to scale so that the costs per health output do not
vary with the scale at which the intervention is undertaken
thus making it necessary only to estimate a single point on
the cost function [6,12]. It is also common practice to
exclude important cost categories such as costs borne by
patients [13]. Further, required information may be pre-
dicted using statistical models rather than actual data col-
lection [9]. A major concern is the severe lack of
information on effectiveness of health interventions [14].
Finally, concerns have been raised over the relevance and
applicability to priority setting in a particular country of
the published allocative cost-effectiveness analyses since
these have often been developed as regional estimates
[15].
Presently, there is not much knowledge of the relative
cost-effectiveness of health services offered in the Zimba-
bwean public health care sector. Such information may
however be useful for assessing the efficiency of resources
used in a situation of dwindling health care funds and
steeply increasing demand. The main objective of this
paper is therefore to provide input into an analysis of
identifying ways of improving the allocative efficiency of
resource utilisation in the health care sector of Zimbabwe.
The general research strategy for achieving this objective is
inspired by the approach previously utilised by the World
Bank [5,6,16,17]. As a first step, this approach entails the
estimation of the level of ill-health of the Zimbabwean
population in 1997 using DALYs as the societal health
outcome measure. Results of this component have been
reported elsewhere [18] and key figures describing the
burden of disease by cause in 1997 have been reproduced
in Annex 1 of the present paper. The second step involves
the estimation of costs per DALY gained for a large
number of health interventions followed by the develop-
ment of essential packages of health interventions which
address large amounts of ill-health at low costs. The
present paper focuses on the second step. In addition,
having finalised this kind of analysis in Zimbabwe, this
study also provides an opportunity to discuss the feasibil-
ity of conducting this very data intensive World Bank
approach in a developing country setting.
The context of the health care system
At the time of this study, the disease pattern in Zimbabwe
is heavily dominated by communicable, maternal, perina-
tal and nutritional conditions [19] similar to other coun-
tries in Sub-Saharan Africa although Zimbabwe is plagued
with an unusually large disease burden due to HIV (Annex
1). The health of the nation has traditionally been a high
priority and large investments in the public health care
sector in the 1980s led to impressive improvements in key
health indicators although the years following 1990 saw a
reversal in most health indicators [20] – a development
further exacerbated in more recent time due to decreasing
GDP, dwindling health care funds and massive emigra-
tion of health sector personnel [21]. The health care sector
is a highly heterogeneous section of the economy. Provi-
sion of health care services is offered by government,
church missions and other NGOs, industries and mines,
private practitioners and traditional healers. Measured by
the number of health facilities, government is the single
most important provider [22]. Private practitioners and
hospitals are relatively abundant in larger cities where
these providers are able to attract large proportions of the
available health personnel. Government of Zimbabwe has
succeeded in organising its own institutions as well as
church mission facilities and some of the private sector
facilities into a four-tiered system of health care service
delivery. Health centres manned by qualified nurses are
the first level followed at the next levels by district, provin-
cial and central hospitals where hospital services of
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increasing complexity are offered requiring more special-
ised personnel and equipment. The head office of the
Ministry of Health and Child Welfare constitutes the high-
est level of the public health care sector and it is the main
actor in terms of health policy making and development.
For instance, the head office is responsible for the alloca-
tion of all government health care funds among health
facilities as well as steering important processes such as
the Zimbabwe Essential Drugs Action Programme
(ZEDAP) which results in a list specifying the most cost-
effective drugs for a large number of health problems [23]
that is used extensively by all health facilities in the coun-
try.
Methods
Choice of interventions for the cost-effectiveness analyses
Curative interventions for the present study included the
treatment of common health problems at hospital inpa-
tient and outpatient departments as well as health centres.
These interventions covered both single treatment epi-
sodes and more long term management of chronic condi-
tions. Preventive interventions included five vertical
activities: residual house spraying to prevent malaria,
immunisation of children (measles, polio, tuberculosis,
diphtheria, pertussis and tetanus), surveillance and tar-
geted supplementary feeding of wasted children, HIV pre-
vention through improved access to treatment of sexually
transmitted infections (STIs) and health promotion of
personal and domestic hygiene in order to decrease the
incidence of diarrhoeal diseases.
Cost data collection and unit costs estimation at selected 
study sites
In order to estimate the costs of individual curative and
preventive health interventions, a number of public
health providers were visited for the collection of the nec-
essary cost data. Study sites were randomly chosen from
all over the country. With respect to curative health inter-
ventions, six health centres out of a total of around 1200
were selected for the cost analysis. Health centres offered
outpatient services and selected preventive activities such
as immunisation. Five district level hospitals including
two mission hospitals from a total of 130 hospitals were
sampled for the costing of inpatient services, surgical pro-
cedures and outpatient services. Finally, two provincial
hospitals (from a total of 8) were randomly selected and
these offered similar services as district hospitals but the
former hospitals were able also to provide more special-
ised services. The highest level, central hospitals, was
excluded from the costing analysis. Preventive interven-
tions were organised in a vertical fashion involving pro-
vincial health offices and district hospitals as well as
services performed by health facilities (e.g. vaccinations at
health centres and hospitals). Two provinces out of a total
of eight were randomly chosen and two districts were ran-
domly selected within each province (a total of 14 dis-
tricts). Finally, the Ministry of Health Headquarters and
two provincial health offices were visited to capture addi-
tional programme costs of curative and preventive inter-
ventions such as central purchasing of drugs and high
level administrative personnel [10].
The costing perspective taken for this study was the health
provider's view (Ministry of Health and Child Welfare)
since the objective of the present cost-effectiveness analy-
sis was to determine how the largest slice of the burden of
disease could be cut using a given government budget
[24].
Activities at each study site incorporated the identifica-
tion, measurement and subsequent valuation of resources
required to offer health services. Government accounting
systems provided at each study site the level of actual,
recurrent expenditure by category including for example
salaries by type of personnel, stationery, electricity, main-
tenance and drugs. With respect to capital inputs at each
study site, a quantity surveyor estimated the present day
construction costs per square metre by type of office or
department. Further, a list of available equipment and fur-
niture was developed and subsequently valued using mar-
ket prices. From these replacement costs of buildings,
equipment and furniture, an annual equivalent was calcu-
lated using the annuitization method [24,25] assuming a
real discount rate of 3% and expected life spans of 30, 7
and 10 years for the mentioned capital inputs.
These costs by category were at each study site allocated to
the health interventions selected for this study. This was
done by applying the standard step-down costing meth-
odology [24,26] consisting initially of categorising activi-
ties (in practice wards and departments) in a study site
into a hierarchical system with the final product (such as
patient care) at the lowest level and with support and
overhead activities at successively higher levels. Subse-
quently, the aggregate costs by category were allocated to
final activities in a step-wise fashion using simultaneous
equation techniques [[24], Ch. 4] and the development of
allocation criteria reflecting actual resource use. At the end
of the standard step-down costing procedure, all costs of a
study site had been distributed to the final service depart-
ments so that an average costs figure could be calculated
by dividing the number of services provided by individual
departments. Micro-costing techniques [27] were used to
supplement the above information in order to achieve
information on interventions against individual diseases.
For instance, a review of a sample of inpatient notes was
performed at hospitals in order to capture the treatment
pattern of the most common health problems. With
respect to the treatment of the less common health prob-
lems, official treatment guidelines were used [23].
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Having finalised the study activities described above, unit
costs of individual curative and preventive services were
available for the study sites included.
Costs of interventions at population level
Unit costs of individual health interventions estimated
from data collected at the study sites were utilised for cal-
culating the total costs of offering this service for a popu-
lation group as a whole. This was done to take account of
the fact that costs and effects measured in DALYs averted
depended on age of onset of disease. The total costs of a
specific curative health intervention were calculated for a
hypothetical district population of 250,000 individuals in
Zimbabwe with the same age and sex distribution and
incidence of diseases as the country as a whole. The
number of treatments for each disease was determined by
incidence and the health seeking behaviour of the popu-
lation. Information on incidence of diseases was drawn
from a national study which provided estimates of new
cases of disease by age and sex groups for the year 1997
[18]. In addition, the proportions of cases by disease likely
to seek treatment were determined based on advice from
clinical experts as well as the National Health Information
System [19]. Using these two types of information, the
total number of treatments by age and sex could be esti-
mated for each disease under study. Subsequently, the
total costs of a curative health intervention were estimated
by multiplying this number with the relevant unit costs:
where Cj is the population level costs of intervention j, Uj
indicates the unit costs of curative health intervention j. In
addition,  is the absolute, annual number of incident
cases of a health problem (which may be treated by inter-
vention j) in population group of age a and sex s while
 is the proportion of incident cases seeking treatment
in the same population group. Outpatient services were
offered both at health centres and hospitals. It was
assumed that 80% of all cases were treated at health cen-
tres and 20% at district hospital outpatient departments
corresponding to the actual health seeking behaviour
[19]. Some health problems required life long treatment
like for instance insulin-dependent diabetes. In these
cases, the specific cost figures estimated for a given length
of time were recalculated to match the life expectancies at
various ages of onset of the disease as indicated in the for-
mula below:
where  is the annual costs at time t for health interven-
tion j for a chronic condition while T(as) indicates the life
expectancy of an individual belonging to population
group of age a and sex s. Future costs were discounted
using a real discount rate r of 3 percent.
The primary preventive interventions incurred costs at dis-
trict and provincial health offices and typically also at the
level of health providers such as health centres and hospi-
tals. The pattern of cost components for preventive inter-
ventions therefore followed the general form:
where Dj and Pj represent the overall costs related to pre-
ventive intervention j at the district and the particular dis-
trict's share of the provincial office respectively. In
addition, Uj denotes the unit costs of preventive activities
such as vaccinations or STI treatments performed at health
centres and hospital outpatient departments. Finally, 
is the absolute number of individuals in population
group of age a and sex s targeted for intervention j and
with  denoting the percentage actually covered. Infor-
mation on the number of individuals in each age and sex
group in the study population could be obtained from the
most recent census [28,29] and updating these figures
using estimates of population growth [30]. Coverage of
the five preventive health interventions was established
through discussions with the responsible staff in the four
districts. For some activities such as immunisation, infor-
mation on coverage was collected as part of a recent
Demographic and Health Survey [31].
Estimation of effectiveness of interventions at population 
level
The benefits of an intervention were measured as the
reduction in the burden of disease (DALYs averted) as a
result of the intervention. Following the Global Burden of
Disease methodology [32-34], the burden of disease for
an individual of sex s dying prematurely at age a, BODas,
and with life expectancy T(as) (or suffering from a disease
episode starting at age a with length T(as)) could be calcu-
lated from the formula:
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where W is a quality adjustment factor (disability weight)
representing different levels of health [[33,35]: Annex 3].
The component Kte-βt is an age weighting curve of an
inverted u-shape so that the relative value of life years in
young adulthood is higher than in other ages while e-r(t-a)
is the discount factor using discount rate r = 0.03. Finally,
rather than using actual life expectancies of the popula-
tion under study, the DALY methodology employs long
life expectancies from a low mortality model life table
(Coale-Demeny West Level 26 [36]). Life expectancies
T(as) therefore depend on both age and sex. The benefit
in terms of DALYs gained from a successful intervention j
for a person of age a and sex s is calculated in the follow-
ing way:
where  is the burden of disease after a successful
intervention. For instance, the number of DALYs gained
for an individual dying prematurely at age a1 without
treatment but postponing death until age a2 (a1 <a2) fol-
lowing an intervention can be calculated using equation
(5). A detailed explanation using worked examples of
how to calculate DALYs for cost-effectiveness analysis has
been presented by Fox-Rushby and Hanson [37].
Effectiveness of health interventions in a real world setting
depend on a wide range of factors [11,38]. Four factors
were identified for the present study as having an impor-
tant influence on the effect of curative interventions: effi-
cacy of individual drugs, diagnostic accuracy,
appropriateness of the treatment prescribed and patient
compliance.
With respect to efficacy, sources of information for this
measure by type of drug were mainly a World Bank review
[5], Cochrane systematic reviews (such as for instance tra-
choma [39]) or articles identified through the Cochrane
register of randomized controlled trials. Very little hard
evidence from the Zimbabwean setting could be found on
the other three factors so estimates of these aspects were
determined for each health problem based on discussions
with clinical experts. In a similar fashion as applied by
Evans et al. [13], the effectiveness of a health intervention
was estimated by reducing the efficacy of the relevant drug
by a factor between 0 and 1. The benefits at population
level in terms of DALYs averted of a specific curative
health intervention j were subsequently calculated as:
where Ej, Bj, Fj and Gj are efficacy of the drug prescribed,
diagnostic accuracy, correct treatment and patient compli-
ance respectively for curative intervention j measured as
percentages. Expressed in words, this equation estimates
the number of individuals cured through treatment j by
excluding ineffective services from the total number of
individuals seeking treatment and translating the result-
ing health benefits into DALYs averted.
A similar procedure was applied to preventive interven-
tions involving first determining the effect under ideal
conditions followed by adjusting this to incorporate real
world conditions. Efficacy of malaria spraying was derived
from a study in South Africa which compared the preva-
lence of malaria infection in sprayed areas and non-
sprayed areas [40]. Similarly, efficacy estimates were
derived for environmental health [41-43], food supple-
mentation [44], vaccines [45,46] and STI syndromic man-
agement [47,48]. The number of DALYs averted at
population level for a given preventive intervention j was
calculated as:
where Ej is the efficacy of the intervention under ideal cir-
cumstances and Rj is any necessary downward adjustment
(less than perfect coverage) of efficacy while  is the
incidence of disease in different age- and sex groups. Cov-
erage of the five preventive health interventions was estab-
lished through discussions with the responsible staff in
the four districts included or in the case of EPI utilising the
Demographic and Health Survey [31].
Calculation of cost-effectiveness ratios
Having estimated the total costs and effectiveness of vari-
ous health interventions, the cost-effectiveness ratio for
intervention j, CERj, was found as:
where costs were estimated using equation (1), (2) or (3)
and effects were estimated using (6) or (7).
Development of essential health packages
The selection of health interventions for essential health
packages may be done by applying different sets of princi-
ples. According to the World Bank principles for develop-
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ing health packages [16], desirable health interventions
are those with low cost-effectiveness ratios and at the
same time address important health problems. Another
possible set of principles is a pure cost-effectiveness crite-
rion [49]. This entails utilising a process consisting of
selecting first the intervention with the lowest cost-effec-
tiveness ratio and then calculating the total costs of avert-
ing this health problem. The subsequent step chooses the
intervention with the second lowest cost-effectiveness
ratio and also calculating the total costs of averting this
health problem and so on until the budget is exhausted.
Assuming that the cost-effectiveness ratios estimated for
the health interventions of this study complied with the
assumptions of perfect divisibility and constant returns to
scale [50,51], the total costs and effects in terms of disease
reduction of various sets of interventions could be esti-
mated. Median cost-effectiveness ratios were utilised for
each type of intervention. Estimates of the burden of dis-
ease by cause which must be addressed by the selected
interventions were obtained from a previous national
study [18] and reproduced in Annex 1. It was further
assumed that 300 millions of Zimbabwe dollars were
available for the essential packages. This corresponded to
just below 10 percent of actual capital and recurrent
expenditure at the national level in the financial year
1997/1998. Two additional restrictions were imposed.
First, the majority of diseases could not be averted at a sin-
gle level of the health system. For instance, if an interven-
tion against pneumonia was selected to be part of the
package, this health problem could not be fully avoided
by offering treatment through health centres. It would be
necessary to offer hospital treatment as well. Secondly, it
was assumed that at most 30 percent of the HIV burden
could potentially be averted through the preventive inter-
vention included in the study (STI treatment) to avoid the
budget being exhausted by this single intervention.
Sensitivity analysis
The sensitivity of the cost-effectiveness ratios was assessed
by varying important parameters and assumptions.
Instead of a 3% discount rate utilised for the baseline cal-
culations of cost-effectiveness ratios, these were recalcu-
lated using discount rates of 6 and 10%. Estimated time
preferences with respect to life years vary a lot [52]
although a recent empirical study in Tanzania suggested a
time preference of a similar size to the range chosen above
[53]. The size of the discount rate affected both the effects
of health interventions through the DALY formula and
the costs of health services. The long life expectancies from
the chosen model life table were replaced by actual,
period life expectancies as recommended in the recent
World Bank health sector priorities review [12]. Much
shorter, actual Zimbabwean life expectancies were esti-
mated based on the population size and the number of
deaths by age and sex obtained from the census of 1997
[30]. Furthermore, rather than the inverted u-shape of the
age weighting function suggested by the DALY methodol-
ogy, an age weighting function with an equal value of 1 on
each life year was used as also suggested by the World
Bank health sector priorities review [12]. Some of the
health facilities visited operated considerably below full
capacity during the study year thus pushing up costs of
services. For the sensitivity analysis, cost-effectiveness
ratios were recalculated under the assumption that all
health facilities were moderately and significantly better
utilised (e.g. 80 and 95% bed occupancy rates in inpatient
departments respectively). Finally, assessing the robust-
ness of the cost-effectiveness ratios to changes in the effec-
tiveness of interventions was very important since this was
an area with little hard evidence. Therefore, cost-effective-
ness ratios were recalculated assuming a lower effective-
ness of individual health interventions than in the
baseline calculations. Calculations were performed utilis-
ing effectiveness estimates that were 90, 70 and 50% of
the baseline estimates.
Results
Combining the estimated costs and effects resulted in a
list of costs per DALY averted for a large number of health
interventions. Table 1 displays the range of costs per DALY
of the health interventions included in this study. The
specification of a range of costs for individual health inter-
ventions reflects the fact that the costs of individual treat-
ments differed in the health facilities and the various
preventive programmes due to such factors as varying
treatment patterns for similar diseases, availability of
resources, degree of capacity utilisation of health facilities
and incidence of diseases.
Among the interventions with the lowest cost-effective-
ness ratios, curative treatment at health centres and hospi-
tal outpatient departments of pneumonia, severe
diarrhoeal diseases, peptic ulcer, dysentery, malaria, tra-
choma, schistosomiasis haematobium and glaucoma
were identified. In addition, curative treatments for
meningococcal meningitis, pneumonia and malaria at
district and provincial hospitals were also in the group of
interventions with low costs per DALY. Preventive inter-
ventions of low costs per DALY included improved STI
treatment to avert new HIV infections and residual house
spraying to avoid malaria infection. In the middle range of
the list of costs per DALY averted, fewer interventions
based at the first level of the delivery system were found.
Treatment of scabies at health centres and hospital outpa-
tient departments was the only exception. With respect to
district and provincial hospitals, the treatment of dysen-
tery, peptic ulcer, six months tuberculosis course, compli-
cated deliveries with minor or major surgery (caesarean
section) and appendectomy were estimated to have costs
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Table 1: Costs per DALY in Z$ by type of intervention (Z$17 = US$1), Zimbabwe, financial year 1997/1998
----- Costs per DALY -----
Disease group and intervention Level of delivery Median Lowest Highest
HIV
Prevention through access to treatment for STIs Vertical programme 129 124 133
Prophylaxis to prevent opportunistic diseases District hospital, health centres 9,959 9,712 11,063
Prophylaxis to prevent opportunistic diseases Provincial hospital, health centres 12,473 11,257 13,777
MALARIA
Treatment as an outpatient Health centres, hospitals 159 127 214
Treatment as an inpatient District hospital 173 141 257
Prevention through residual house spraying Vertical programme 185 81 466
Treatment as an inpatient Provincial hospital 287 225 327
PNEUMONIA
Treatment as an outpatient Health centres, hospitals 42 35 53
Treatment as an inpatient District hospital 130 102 182
Treatment as an inpatient Provincial hospital 295 258 317
DIARRHOEAL DISEASES
Treatment an outpatient Health centres, hospitals 70 52 102
Prevention through hygiene promotion Vertical programme 1,011 985 1,054
DYSENTERY
Treatment as an outpatient Health centres, hospitals 85 77 102
Treatment as an inpatient District hospital 531 461 757
Treatment as an inpatient Provincial hospital 908 814 1,002
TUBERCULOSIS
Six months treatment with DOTS District hospital, health centres 815 706 878
Six months treatment with DOTS Provincial hospital, health centres 973 907 1,085
MALNUTRITION
Surveillance and targeted food supplementation Vertical programme 1,489 1,457 1,524
MENINGITIS
Treatment as an inpatient (bacterial men.) District hospital 281 266 408
Treatment as an inpatient (bacterial men.) Provincial hospital 488 404 580
Treatment as an inpatient (meningococcal men.) District hospital 98 89 144
Treatment as an inpatient (meningococcal men.) Provincial hospital 176 147 208
PELVIC INFLAMMATORY DISEASE
Treatment as an outpatient Health centres, hospitals 365 346 411
Treatment as an inpatient District hospital 3,666 3,083 4,286
Treatment as an inpatient Provincial hospital 5,362 3,181 7,543
SYPHILIS
Treatment as an inpatient District hospital 3,725 3,429 4,514
Treatment as an inpatient Provincial hospital 7,612 6,263 9,126
URETHRAL DISCHARGE IN MALE
Treatment as an outpatient Health centres, hospitals 13,390 12,599 15,277
VAGINAL DISCHARGE
Treatment as an outpatient Health centres, hospitals 3,495 3,312 3,955
CHILDHOOD CLUSTER DISEASES
Prevention through vaccination Vertical programme 586 506 700
SCHISTOSOMIASIS HAEMATOBIUM
Treatment as an outpatient Health centres, hospitals 259 160 317
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SCHISTOSOMIASIS MANSONI
Treatment as an outpatient Health centres, hospitals 431 267 528
TRACHOMA
Treatment as an outpatient Health centres, hospitals 154 150 165
BACTERIAL CONJUNCTIVITIS
Treatment as an outpatient Health centres, hospitals 235 219 271
GLAUCOMA
Treatment as an inpatient District hospital 211 160 342
Treatment as an inpatient Provincial hospital 419 340 508
MINOR COMPLICATIONS IN DELIVERY
Surgery District hospital 515 408 717
Surgery Provincial hospital 757 443 1,072
MAJOR COMPLICATIONS IN DELIVERY
Surgery (caesarean section) District hospital 771 591 1,214
Surgery (caesarean section) Provincial hospital 935 621 1,249
APPENDICITIS
Surgery District hospital 606 531 1,136
Surgery Provincial hospital 1,007 757 1,138
INGUINAL HERNIA
Surgery District hospital 314 201 610
Surgery Provincial hospital 562 557 567
ABSCESS ON EXTREMITY
Surgery District hospital 954 837 1,796
Surgery Provincial hospital 1,555 1,175 1,761
DIABETES MELLITUS
Inpatient stay and follow-up at health centres District hospital, health centres 4,999 4,881 5,330
Inpatient stay and follow-up at health centres Provincial hospital, health centres 5,157 4,749 5,565
HYPERTENSION
Inpatient stay and follow-up at health centres District hospital, health centres 8,510 8,419 9,032
Inpatient stay and follow-up at health centres Provincial hospital, health centres 9,732 9,094 10,370
RHEUMATIC FEVER
Inpatient stay and follow-up at health centres District hospital, health centres 3,241 3,012 3,387
Inpatient stay and follow-up at health centres Provincial hospital, health centres 3,935 3,777 4,093
GASTRITIS
Treatment as an outpatient Health centres, hospitals 394 362 461
Treatment as an inpatient District hospital 1,292 1,203 2,007
Treatment as an inpatient Provincial hospital 2,465 1,999 2,989
PEPTIC ULCER
Treatment as an outpatient Health centres, hospitals 95 75 130
Treatment as an inpatient District hospital 428 397 684
Treatment as an inpatient Provincial hospital 850 686 1,036
GASTROENTERITIS
Treatment as an outpatient Health centres, hospitals 331 279 425
Treatment as an inpatient District hospital 895 830 1,287
Treatment as an inpatient Provincial hospital 1,545 1,295 1,825
SCABIES
Treatment as an outpatient Health centres, hospitals 1,074 890 1,403
Table 1: Costs per DALY in Z$ by type of intervention (Z$17 = US$1), Zimbabwe, financial year 1997/1998 (Continued)
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IMPETIGO
Treatment as an outpatient Health centres, hospitals 15,745 13,256 20,249
BODY RINGWORM
Treatment as an outpatient Health centres, hospitals 17,266 13,920 23,130
TONSILLITIS
Treatment as an outpatient Health centres, hospitals 53,087 49,429 61,289
Table 1: Costs per DALY in Z$ by type of intervention (Z$17 = US$1), Zimbabwe, financial year 1997/1998 (Continued)
per DALY averted in the middle range. Hygiene promo-
tion in the community to prevent diarrhoea was also in
the middle range at costs per DALY averted of Z$1,011.
The least cost-effective interventions of the list incorpo-
rated only health facility-based curative interventions.
Health centre and hospital outpatient department inter-
ventions incorporated treatment for urethral discharge in
males, body ringworm, impetigo and tonsillitis. The rea-
sons for the high costs of these interventions were that
these conditions were mild, often self-resolving and the
treatment was in some cases not very effective due to low
efficacy of the drug recommended. At hospitals, treatment
interventions aimed at insulin-dependent diabetes,
prophylaxis to avert opportunistic infections in HIV/AIDS
patients, hypertension, pelvic inflammatory disease and
syphilis were estimated to have high costs per DALY.
The estimated cost-effectiveness ratios were utilised to
develop a package of health interventions by applying the
World Bank criteria for selection of essential activities
(cost-effective and addressing important health prob-
lems). As displayed in Table 2, these criteria suggested a
variety of health interventions aimed at relieving and
averting the health problems due to HIV, pneumonia,
diarrhoeal diseases, protein-energy-malnutrition, menin-
gitis, malaria, complicated deliveries and tuberculosis.
Potentially, these interventions could avert 26.4 percent
of the burden of disease in 1997 at total costs of Z$300
million. The above calculations indicated that relatively
few additional resources could address a large percentage
of the present burden of disease.
Using instead a selection procedure based on a pure cost-
effectiveness criterion resulted in the interventions dis-
played in Table 3. Inclusion of health interventions for
this package was continued until the total costs were at an
identical expenditure level as the package described
above. Interventions addressing important health prob-
lems like HIV, pneumonia, diarrhoeal diseases, malaria,
tuberculosis and complicated deliveries were included in
this package as was the case of the package described
above. However, instead of including supplementary
feeding against malnutrition, this package included rela-
tively minor health problems like bacterial conjunctivitis,
gastritis, childhood cluster diseases, glaucoma, peptic
ulcer, schistosomiasis and trachoma. The total package
could potentially avert a slightly higher share of the 1997
disease burden than the above package (27.2 versus 26.4
percent).
Generally, the cost-effectiveness ratios presented in the
tables suggested that there was a good potential for
improving the allocative efficiency in the public health
care sector of Zimbabwe. Four general strategies could be
Table 2: Burden of disease averted and total costs of a package of health interventions selected based on cost-effectiveness and relative 
importance of disease criteria, Zimbabwe, financial year 1997/1998
Disease group Intervention Level of delivery % of 1997 disease
burden averted
Total costs in
millions of Z$
HIV Prevention Vertical programme 14.6 93.1
Pneumonia Treatment Outpatient care, inpatient care 2.7 19.1
Diarrhoeal diseases Treatment Outpatient care 2.4 8.5
Malaria Treatment/
prevention
Outpatient care, inpatient care,
vertical programme
1.8 16.0
Tuberculosis Treatment Inpatient care, DOTS 1.6 51.9
Complicated delivery Treatment Inpatient care 1.0 35.1
Meningitis Treatment Inpatient care 0.9 12.3
Dysentery Treatment Outpatient care, inpatient care 0.7 17.8
Protein-energy malnutrition Prevention Vertical programme 0.6 46.2
Total 26.4 300.0
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outlined. Firstly, there were great differences in the esti-
mated cost-effectiveness ratios placed at the top and at the
bottom end of the cost per DALY league table for Zimba-
bwe (Table 1). In principle, therefore, substantial
improvements in the allocative efficiency could be
achieved by a reallocation of resources from the interven-
tions with high cost-effectiveness ratios to interventions
with low cost-effectiveness ratios. Secondly, it appeared
beneficial to put particular attention to a narrow range of
interventions with low cost-effectiveness ratios. The calcu-
lations behind the development of the two intervention
packages (Tables 2 and 3) indicated that as much as one
quarter of the total burden of disease could be averted by
focusing on a few interventions at a level of total costs cor-
responding to ten percent of the current, national expend-
iture at that time. Thirdly, the cost-effectiveness figures
estimated also confirmed the findings of other studies
(e.g. [54,55]) namely that for the same disease, it was
more attractive from an efficiency point of view to have
the health problem taken care of at the lowest level of the
referral system as possible. Comparing the cost-effective-
ness ratios for the same health problem, the highest ratios
were generally found in provincial hospitals followed by
district level hospitals and outpatient care. According to
calculations not presented in Table 1, cost-effectiveness
ratios at health centres were also lower than hospital out-
patient departments. In other words, this suggested that
there could be substantial gains from utilising the public
health care sector facilities in the hierarchical manner that
was intended (e.g. only treating difficult health problems
at high level facilities and mild cases at the lowest levels).
Fourthly, there appeared to be a potential for designing
very cost-effective preventive health interventions at the
expense of curative interventions. The estimated costs per
DALY for five preventive health programmes included in
this study were all relatively low.
The sensitivity analysis presented in Table 4 suggested that
increasing the discount rate to 6%, utilising the actual
Zimbabwean life expectancies, applying equal age weight-
ing or assuming a better capacity utilisation of health
facilities had relatively minor effects on the cost-effective-
ness ratios. As compared to the baseline estimates of Table
1, these assumptions resulted in a difference in costs per
DALY of less than 20% for the majority of the 65 interven-
tions included in the study. In addition, the majority of
interventions had shifted their rank by three places or less
in the rank order of interventions by cost-effectiveness
ratio. Contrary to these observations, utilising a higher
discount rate of 10% had more profound effects on the
figures. Cost-effectiveness ratios of most interventions
rose by 30% or more and the rank changed by four steps
and above for 24 interventions. Reducing the estimates of
effectiveness in individual health interventions, the rank
of health interventions was more strongly affected at suf-
ficiently large decreases in intervention effectiveness. For
instance, if intervention effectiveness was 50% of the orig-
inal estimates, more than half the interventions decreased
Table 3: Burden of disease averted and total costs of a package of health interventions selected based on a pure cost-effectiveness 
criterion, Zimbabwe, financial year 1997/1998
Disease group Intervention Level of delivery % of 1997 disease
burden averted
Total costs
in millions of Z$
HIV Prevention Vertical programme 14.6 93.1
Pneumonia Treatment Outpatient care, inpatient care 2.7 19.1
Diarrhoeal diseases Treatment Outpatient care 2.4 8.5
Malaria Treatment/
prevention
Outpatient care, inpatient care, 
vertical programme
1.8 16.0
Tuberculosis Treatment Inpatient care, DOTS 1.4 45.3
Meningitis Treatment Inpatient care 0.9 12.3
Dysentery Treatment Outpatient care, inpatient care 0.7 17.8
Complicated delivery Treatment Inpatient care 0.5 15.5
Gastritis Treatment Outpatient care, inpatient care 0.4 24.9
Trachoma Treatment Outpatient care 0.4 2.7
Glaucoma Treatment Inpatient care 0.4 4.8
Gastroenteritis Treatment Outpatient care, inpatient care 0.3 15.7
Inguinal hernia Treatment Inpatient care 0.1 2.7
Childhood cluster Prevention Vertical programme 0.1 3.9
Peptic ulcer Treatment Outpatient care, inpatient care 0.1 2.8
Pelvic inflam. disease Treatment Outpatient care, inpatient care 0.1 9.6
Appendicitis Treatment Inpatient care 0.1 3.4
Bacterial conjunctivitis Treatment Outpatient care 0.1 1.0
Schistosomiasis Treatment Outpatient care 0.1 1.0
Total 27.2 300.0
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their ranks by more than five places. In particular, the
ranks of hospital treatment of bacterial meningitis,
malaria, pneumonia, tuberculosis and surgical interven-
tions as well as health centre treatment of conjunctivitis,
schistosomiasis haematobium and gastroenteritis were
sensitive to changes in intervention effectiveness.
Discussion
Limitations of the approach applied in Zimbabwe
The above findings must be seen in the light of the limita-
tions of the study. As a starting point, the cost function
assumed for this study was simple and restrictive. The
assumptions of constant returns to scale and perfect divis-
ibility ensured that the average costs per unit of health of
any given health intervention were the same irrespective
of the level of production. These assumptions facilitated
the identification of which interventions should go into
an essential health package as well as the exact level of
health services production necessary to eliminate the dis-
ease burden of a health problem. While there may be sev-
eral reasons for deeming these assumptions unrealistic,
they are frequently applied both for curative and preven-
tive interventions [56-58]. Relieving the assumptions of
constant returns to scale and perfect divisibility to develop
cost functions with non-constant unit costs and limited
possible production levels would require more compli-
cated optimising techniques such as linear, non-linear or
integer programming [59,60].
Much of the information necessary for costing of health
interventions was available in principle in the sense that
the majority of health facilities and vertical programmes
visited kept a good record of most of the resources used
although only at an aggregate level (i.e. total resources for
a whole hospital and not broken down by diagnosis).
However, the costing exercise was nevertheless in some
aspects not as detailed and extensive as could have been
desired mainly as a result of limited research resources.
First, a relatively limited number of health centres, hospi-
tals and preventive activities in districts were included as
study sites leading to a risk of not capturing a representa-
tive pattern of unit costs for the country as a whole. Sec-
ond, the costing methodology also involved a number of
simplifying assumptions in the data collection at study
sites including, for instance, that the average personnel
and other costs per inpatient day were the same irrespec-
tive of the diagnosis of a patient and that the treatment of
most conditions followed the treatment guidelines [23]
rather than the pattern found through the micro-costing
data collection. Third, the number of health interventions
included was relatively low due in particular to problems
of identifying sufficient information to estimate effective-
ness of interventions.
Perhaps the most serious limitation was the scarcity of evi-
dence on effectiveness of health interventions and of
health systems research in Zimbabwe. The observations
made by several authors [14,61,62] that we desperately
lack data on these aspects are therefore also very relevant
for the Zimbabwean situation. Research on factors influ-
encing how health interventions work in the real world
was extremely limited. One example of an extremely use-
ful piece of research for the purposes of the present study
was the finding of Vundule and Mharakurwa [63] that as
Table 4: Influence of selected assumptions and parameters on the level of cost-effectiveness ratios and the rank order of interventions 
by cost-effectiveness ratios as compared to baseline estimates
Assumption or
parameter investigated
Difference in costs per DALY
as compared to baseline
Difference in rank order 
as compared to baseline
--------- change in percent --------- ------ places up or down ------
0–10 10–20 20–30 ≥ 30 0–1 2–3 4–5 ≥ 6
---- Number of interventions ---- ---- Number of interventions ----
Discount rate 6% 55 0 4 6 47 13 3 2
Discount rate 10% 8 3 2 52 25 16 15 9
Zimbabwean life expectancies 20 38 3 4 57 7 1 0
Equal value on each life year 11 34 14 6 45 18 1 1
Capacity utilisation 80% 43 11 10 1 41 21 3 0
Capacity utilisation 95% 19 20 14 12 32 28 4 1
Effectiveness 90% of baseline 2 63 0 0 41 21 3 0
Effectiveness 70% of baseline 0 0 2 63 8 22 19 16
Effectiveness 50% of baseline 0 0 0 65 5 9 10 41
Note: The median costs per DALY utilising an alternative assumption or parameter were compared to the median costs of Table 1. Likewise, the 
rank order of interventions by median cost-effectiveness ratios utilising an alternative assumption or parameter were compared to the rank order 
of Table 1.
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many as 21 percent of villagers might refuse access of
spraying teams to some rooms during residual house
spraying. For the present study, the necessary information
required to estimate effectiveness was for the majority of
health interventions based on best guesses by clinical
experts.
Operational lessons learned
The present exercise replicated the methods underlying
the 1993 World Development Report [16] and utilised
also in more recent analyses [6]. The Zimbabwean
research proved very data intensive and most of the
needed information to determine the burden of disease,
costs and effects of health interventions was not immedi-
ately available which required very extensive data collec-
tion in the field. Results presented here as well as the
burden of disease estimates published previously [18]
represented what was feasible within the time and
resources allocated. The net time of work for this research
was approximately one and a half year with one
researcher, a study administrator and eight research assist-
ants working full time and a core team of ten researchers
and civil servants from selected ministries working on a
part-time basis (3–6 hours per individual per week on
average). Despite this substantial resource input, it was
deemed necessary to adopt a number of simplifying
assumptions and less extensive data collection activities
some of which have been discussed above.
Substantial efforts were invested in searching for pub-
lished and unpublished studies on the effectiveness of
health interventions as well as health systems research on
how health interventions operated in reality in Zimba-
bwe. The lack of knowledge was a main obstacle to this
study and came to some extent as a surprise to research
team. If this situation had been anticipated, the data col-
lection would have focused more on collecting additional
information on the functioning of the health system
which could subsequently have been utilised to adjust the
findings from efficacy studies measuring impact under
ideal conditions to arrive at estimates of effectiveness for
the Zimbabwean situation. Efficacy studies from similar
settings in Africa are more plentiful [i.e. [64,65]]. One
example of a possible useful piece of health systems
research would be a review of the health centres of this
study to investigate the compliance of tuberculosis
patients on directly observed treatment short course
(DOTS).
The characteristics described above had as a consequence
that it was possible to include only a limited number of
interventions for the cost-effectiveness analysis. In other
words, cost-effectiveness assessments were not performed
for a whole range of relevant interventions. For instance,
interventions directed at health problems with a signifi-
cant burden of disease such as depression and anxiety dis-
orders and road traffic accidents were not included.
Preventive interventions were incorporated only in a lim-
ited number so that many common HIV preventive activ-
ities were left out of the analysis including condom
promotion, voluntary testing and counselling, peer-based
programmes to educate high risk groups and prevention
of mother-to-child transmission but also preventive activ-
ities against non-communicable diseases and injuries. As
a result of these shortcomings, it is not possible to con-
clude that we have now identified the best or the most
efficient essential package of care which must be focused
on for many years. There may be other more efficient
packages since it is possible only able to make conclusions
with regards to reallocations among the interventions
investigated in this study. The present endeavour may
more appropriately be seen as just one possible direction
towards improving allocative efficiency in the health care
sector.
Nevertheless, the present exercise was still extremely use-
ful. It captured costs per DALY of a range of health inter-
ventions representing the situation in the health care
sector at the time of study. Before this study, there was
only very limited and scattered information on the costs
and even less on the effects of health interventions [55,66-
68]. This study also demonstrated what was possible in a
setting like Zimbabwe given a certain level of research
resources but also that most of the limitations mentioned
could in principle be overcome if more research resources
were available. For instance, the cost data collection could
have been extended and more health systems research
could have been planned to inform the effectiveness com-
ponent which could have enlarged the range of health
interventions for the cost-effectiveness analysis. Finally,
this study highlighted the most important gaps in the
knowledge for priority setting i.e. the shortage of hard evi-
dence on effectiveness of health services.
Utilisation of results
According to the health information system, acute respira-
tory infections, malaria and skin diseases are the most
common health problems treated at outpatient depart-
ment level whereas pulmonary tuberculosis (as much as
22% of all inpatient days in the country), malaria and
pneumonia are the most frequent diagnoses in individu-
als admitted as inpatients at hospitals in 1998 [19]. Large
proportions of pulmonary tuberculosis and pneumonia
cases are probably caused by underlying HIV [18]. Most of
these interventions have been deemed relatively cost-
effective in this study and are components of the packages
suggested (Tables 2 and 3). However, the present study
suggests that HIV prevention is more cost-effective than
treatment (including TB treatment) which has been con-
firmed by other studies [69]. Also malaria prevention in
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high incidence areas appeared to have lower costs per
DALY compared to treatment. The central level of Ministry
of Health controls the overall allocation of funds between
hospitals, where the majority of interventions are curative,
and preventive programmes. It is therefore possible to
change priorities at the macro level by shifting the balance
in favour of the preventive component and furthermore to
focus on HIV and malaria prevention. Apart from decid-
ing the funds available for individual hospitals, the cen-
tral level of Ministry of Health has less influence on the
priority setting at health centre and hospital level where
the interventions offered to a large extent are determined
by self-referral of patients. Rationing decisions for treating
different patient groups will be done by health practition-
ers and may involve a variety of considerations and values
(see i.e. [70]) resulting in a focus which may differ from
priority setting based on pure cost-effectiveness criteria.
The present study pointed to a direction of focus among
curative health interventions which may be difficult to
enforce among health practitioners. Increased legitimacy
and support among clinicians and other health sector per-
sonnel as well as patients may be secured if they are
involved in the priority setting procedure through a con-
sultative process where these groups are allowed to incor-
porate their own values. For instance, several authors have
suggested that other criteria such as equity, severity of dis-
ease, age of patient groups and capacity to benefit may
affect the rank order of health priorities in the opinion of
health personnel [71-73].
Conclusion
The previous pages showed that it was feasible to conduct
cost-effectiveness analyses for a large number of health
interventions in a developing country like Zimbabwe
using a consistent methodology similar to the analysis
performed at a general, non-country specific level by the
World Bank [16]. The analyses performed in Zimbabwe
suggested that cost-effective health interventions were
available for some of the major health problems includ-
ing HIV, pneumonia, tuberculosis and malaria. In addi-
tion, the analysis suggested that there was substantial
potential for improving the efficiency with which
resources are utilised in the public health care sector.
Limitations to the approach applied in Zimbabwe were
identified including short cuts in the costing methodology
and scarcity of evidence on effectiveness of health inter-
ventions. As a result, important health interventions were
not incorporated in the cost-effectiveness analysis. How-
ever, most of the obstacles identified in this study could in
principle be overcome by adding more research resources.
For instance, adding a large component of health systems
research on the actual functioning of the health system
would improve the effectiveness estimates and enable the
inclusion of more health interventions in the cost-effec-
tiveness analysis. A larger number of health interventions
assessed by cost-effectiveness analysis would in addition
make the subsequent identification of an essential pack-
age of health interventions more credible.
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Annex 1
See Table 5.
Table 5: Annex 1: Total burden of disease as measured by 
Disability-Adjusted Life Years (DALYs) and distribution by the 
top 25 underlying causes, Zimbabwe, 1997
Total DALYs 4,948,172
Cause %
HIV 48.6
Depression and anxiety disorders 5.6
Diarrhoeal diseases 3.5
Low birth weight 3.4
Lower respiratory tract infections 3.3
Birth asphyxia and birth trauma 2.7
Protein-energy malnutrition 2.3
Malaria 1.8
Tuberculosis 1.6
Road traffic accidents 1.1
STIs excluding HIV 1.0
Iron-deficiency anaemia 1.0
Bacterial meningitis 0.9
Maternal sepsis 0.9
Sense organ diseases 0.9
Self-inflicted injuries 0.8
Cerebrovascular disease 0.7
Endocrine disorders 0.6
Alcohol dependence 0.6
Rheumatic heart disease 0.6
Obstructed labour 0.5
Hypertensive heart disease 0.5
Diabetes mellitus 0.5
Asthma 0.5
Inflammatory heart disease 0.5
All other conditions 15.8
Source: [18].
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